Clinical Utility of Combined Plasma and Tissue NGS in Patients with Advanced, Treatment-Naive, Non-small Cell Lung Cancer

H. Bote de Cabo, M. Siringo, E. Garcia-Lorenzo, A. Castelo,E. Conde,S. Hernandez, F. Lopez-Rios Moreno,M. Herrera,J. Baena, Y. Ruano-Dominguez,A. B. Enguita, U. Perez,L. Paz-Ares,J. Zugazagoitia

Journal of Thoracic Oncology（2023）

引用 0|浏览1

暂无评分

摘要

The incremental clinical value of performing both tissue and plasma next-generation sequencing (NGS) to detect actionable alterations (AA) in advanced non-small cell lung cancer (aNSCLC) has not been comprehensively assessed. We aimed to study the clinical utility of performing both techniques in patients with newly diagnosed aNSCLC.

查看译文

关键词

Next-generation sequencing,Advanced non-small cell lung cancer,Actionable alterations

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要